메뉴 건너뛰기




Volumn 25, Issue 33, 2007, Pages 5153-5154

Toward progression-free survival as a primary end point in advanced colorectal cancer

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; RALTITREXED;

EID: 36849069358     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.6796     Document Type: Editorial
Times cited : (29)

References (3)
  • 1
    • 36849078044 scopus 로고    scopus 로고
    • Progression-free survival is a surrogate for survival in advanced colorectal cancer
    • Buyse MM, Bursykowski T, Carroll K, et al: Progression-free survival is a surrogate for survival in advanced colorectal cancer. J Clin Oncol 25:5218-5224, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 5218-5224
    • Buyse, M.M.1    Bursykowski, T.2    Carroll, K.3
  • 2
    • 0001863948 scopus 로고    scopus 로고
    • The validation of surrogate endpoints in meta-analyses of randomized experiments
    • Buyse M, Molenberghs G, Burzykowski T, et al: The validation of surrogate endpoints in meta-analyses of randomized experiments. Biostatistics 1:49-67, 2000
    • (2000) Biostatistics , vol.1 , pp. 49-67
    • Buyse, M.1    Molenberghs, G.2    Burzykowski, T.3
  • 3
    • 0035371228 scopus 로고    scopus 로고
    • Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma
    • Louvet C, de Gramont A, Tournigand C, et al: Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma, Cancer 91:2033-2038, 2001
    • (2001) Cancer , vol.91 , pp. 2033-2038
    • Louvet, C.1    de Gramont, A.2    Tournigand, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.